Bicycle Therapeutics CFO corrects 980-share omission
The amended ownership report also includes 980 ordinary shares that had been inadvertently omitted from earlier reports.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Bicycle Therapeutics plc (BCYC) Chief Financial Officer Travis Alvin Thompson reported direct holdings of 9,074 ordinary shares as of June 22, 2023. The holdings include restricted stock unit awards: 3,094 RSUs vest in 11 equal quarterly installments beginning July 3, 2023; 5,000 RSUs vest one-fourth on January 3, 2024, with the remaining RSUs vesting in 12 equal quarterly installments thereafter.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Ordinary Shares F1, F2 | -- | -- | -- |
Footnotes (2)
- F1. Includes restricted stock unit ("RSU") awards. 3,094 RSUs shall vest in eleven equal quarterly installments commencing on July 3, 2023. 5,000 RSUs shall vest one-fourth (1/4) of the total number of RSUs on January 3, 2024, and the remaining RSUs shall vest in 12 equal quarterly installments thereafter.
- F2. Includes 980 ordinary shares that were inadvertently omitted from the Reporting Person's original Form 3, and also were omitted from all subsequent Forms 4 filed by the Reporting Person.
Key Figures
Key Terms
restricted stock unit ("RSU") awards financial
vest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.